Skip to main content

Table 1 Relationship between circulating tumor cells (CTCs) and clinicopathological characteristics in advanced colorectal cancer

From: Circulating tumor microemboli (CTM) and vimentin+ circulating tumor cells (CTCs) detected by a size-based platform predict worse prognosis in advanced colorectal cancer patients during chemotherapy

Characteristics

No. of patients (%)

CTCs

P value

Positive

Negative

All patients

98 (100)

48 (49.0)

50 (51.0)

 

Gender

Male

61 (62.2)

31 (50.8)

30 (49.2)

0.640

Female

37 (37.8)

17 (45.9)

20 (54.1)

Age (median 52, years)

<60

60 (61.2)

30 (50.0)

30 (50.0)

0.800

≥60

38 (38.8)

18 (47.4)

20 (52.6)

Tumor size (cm)

<5

43 (43.9)

20 (46.5)

23 (53.5)

0.666

≥5

55 (56.1)

28 (50.9)

27 (49.1)

Tumor location

Colon

58 (59.2)

29 (50.0)

29 (50.0)

0.808

Rectum

40 (40.8)

19 (47.5)

21 (52.5)

Histology differentiation

Poor

23 (23.5)

18 (78.3)

5 (21.7)

0.043*

Middle

54 (55.1)

23 (42.6)

31 (57.4)

Well

21 (21.4)

7 (33.3)

14 (66.7)

Depth of invasion

T1 + T2

15 (15.3)

6 (40.0)

9 (60.0)

0.135

T3

25 (25.5)

11 (44.0)

14 (56.0)

T4a

47 (48.0)

22 (46.8)

25 (53.2)

T4b

11 (11.2)

9 (81.8)

2 (18.2)

Lymphatic invasion

N0

30 (31.3)

12 (38.7)

19 (61.3)

0.049*

N1

22 (22.2)

7 (31.8)

15 (68.2)

N2a

22 (22.2)

13 (59.1)

9 (40.9)

N2b

24 (24.2)

16 (66.7)

8 (33.3)

TNM stage

III

17 (17.3)

4 (23.5)

13 (76.5)

0.023*

IVa

22 (22.5)

9 (40.9)

13 (59.1)

IVb

59 (60.2)

35 (59.3)

24 (40.7)

CEA (ng/ml)

≤10

54 (55.1)

20 (37.0)

34 (63.0)

0.014*

>10

44 (44.9)

28 (63.8)

16 (36.4)

CA199 (U/ml)

≤37

57 (58.2)

24 (42.1)

33 (57.9)

0.151

>37

41 (41.8)

24 (58.5)

17 (41.5)

  1. Italic values indicate statistically significant associations
  2. * P ≤ 0.05